Boston, MA -- (SBWIRE) -- 06/18/2014 -- Current value sales growth for dermatologicals in 2013 was higher than review period average growth of 2%. 2012 was the only year when value sales decreased due to the poor performance of topical antifungals, vaginal antifungals and haemorrhoid treatments. In 2013, all dermatologicals recorded positive value sales growth mainly driven by increasing prices, while volume sales stagnated in most product areas.

Competitive Landscape

Bayer Hungaria Kft led sales of dermatologicals in 2013 with 29% value share due to its leading antifungal brand Canesten and its variants. Bayer's Bepanthen brand was also among the top brands in nappy (diaper) rash treatments. Egis Gyogyszergyar Nyrt ranked second with 9% value share as the company's Reparon brand led sales of haemorrhoid treatments and marketed such popular brands as Betadine, Alsol and Telviran. PGT Healthcare ranked third accounting for 8% value share mainly due to the ongoing popularity of its Neogranormon brand.

View Full Report Details and Table of Contents

Industry Prospects

Dermatologicals is expected to record moderate value sales growth over the forecast period. Growth will be limited by strengthening competition with cosmeceuticals that offer a widening range of medicated-type products. However, leading brands will probably be able to maintain their shares due to long traditions, acceptable price and frequent advertisements. Innovation will remain at a low level and thus sales will not increase significantly but only marginally with a value CAGR of 1% in constant 2013 prices over the forecast period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Hungary with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Hungary, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Hungary market research report includes:

- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

- What is the market size of Medicated Skin Care in Hungary?
- What are the major brands in Hungary?
- What are the most popular formats for acne treatments?

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Consumer Goods research reports at Fast Market Research

You may also be interested in these related reports:

- Dermatologicals in the US
- Dermatologicals in Israel
- Dermatologicals in Ireland
- Dermatologicals in Japan
- Dermatologicals in Bolivia
- Dermatologicals in Bosnia-Herzegovina
- Dermatologicals in Ukraine
- Dermatologicals in South Korea
- Dermatologicals in the United Arab Emirates
- Dermatologicals in Brazil